Whither the lipid profile: Feast, famine, or no free lunch?

Clinical Chemistry

Volumn 57, Issue 3, 2011, Pages 363-365

  Watts, Gerald F ^a   Cohn, Jeffrey S ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACCURACY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIET RESTRICTION; DYSLIPIDEMIA; EDITORIAL; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID ANALYSIS; POSTPRANDIAL STATE; PREDICTION; QUALITY CONTROL; RISK ASSESSMENT; STANDARD; TRIACYLGLYCEROL BLOOD LEVEL;

BLOOD CHEMICAL ANALYSIS; DYSLIPIDEMIAS; EATING; FASTING; HUMANS; LIPID METABOLISM; LIPIDS;

EID: 79952217317     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.160093     Document Type: Editorial

References (15)

1. Tiyyagara SR, Smith DA. Standard lipid profile. Clin Lab Med 2006;26:707-32. (Pubitemid 44781050)
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
3. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
4. Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008;118:2047-56.
5. Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009;302:1993-2000.
6. Nordestgaard BG, Langsted A, Freiberg JJ. Nonfasting hyperlipidaemia and cardiovascular disease. Curr Drug Targets 2009;10:328-35.
7. Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003;46:733-49.
8. Langsted A, Nordestgaard BG. Nonfasting lipids, lipoproteins and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study. Clin Chem 2010;57:482-489.
9. van Dieren S, Nothlings U, van der Schouw YT, Spijkerman AMW, Rutten GEHM, van der A DL, et al. Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus. Diabetologia 2010;54:73-7.
10. Cohn JS. Postprandial lipemia and remnant lipoproteins. Clin Lab Med 2006;26:773-86. (Pubitemid 44716508)
11. Bruznell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, et al. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 2008;31:811-21.
12. Taskinen MR, Barter PJ, Ehnholm C, Sullivan DR, Mann K, Simes J, et al., on behalf of the FIELD study investigators. Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes. Diabetologia 2010;53:223-9.
13. Mora S, Rifai N, Burning JE, Ridker PM. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2010;118:993-1001.
14. Mora S, Rifai N, Burning JE, Ridker PM. Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27331 women. Clin Chem 2009;55:888-94.
15. Lund SS, Petersen M, Frandsen M, Smidt UM, Parving HH, Vaag AA, Jensen T. Agreement between fasting and postprandial LDL cholesterol measured with 3 methods in patients with type 2 diabetes mellitus. Clin Chem 2011;57:298-308.